CD8A and COVID-19: Our results demonstrated that a significant proportion of COVID-19 patients contained virus-specific T cells (34.83% for CD4+, Fig. 1d; 49.44% for CD8+, Fig. 1e; and cut off = 0.1%) at 48–86 days after disease onset.